Filing Details
- Accession Number:
- 0000059478-18-000210
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-31 12:40:57
- Reporting Period:
- 2018-08-29
- Accepted Time:
- 2018-08-31 12:40:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1403752 | Zymeworks Inc. | ZYME | Pharmaceutical Preparations (2834) | IN |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 59478 | Lilly Eli & Co | Lilly Corporate Center Indianapolis IN 46285 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-08-29 | 2,312 | $14.26 | 3,924,294 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-30 | 3,440 | $14.35 | 3,920,854 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $14.25 to $14.30. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $14.25 to $14.50. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
